News AI-backed blood test could reduce reliance on cancer drugs Approach could reduce use of cancer drugs.
News Smartphone selfie app can diagnose pancreatic cancer App could help identify early signs of the disease.
News NICE recommends Celgene pancreatic cancer drug Abraxane finally gets NHS funding following price cut.
News UK and US spearhead search for drugs targeting RAS mutations Cancer Research UK and its Cancer Research Technology Pioneer Fund have joined with the US National Cancer Institute (NCI) to test new molecules targeting RAS mutations.
News NICE rejects Shire pancreatic cancer drug Onivyde not eligible for Cancer Drugs Fund, says NICE.
News Shire's Onivyde pancreatic cancer drug approved in EU Drug approved in metastatic adenocarcinoma of the pancreas.
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
